US FDA pauses Gilead trials testing experimental HIV pill combination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. JPM
5. ICLR
6. USO
7. FUL
8. LAES
9. IBM

Go back to US FDA pauses Gilead trials testing experimental HIV pill combination
Gilead Sciences (NASDAQ: GILD) Delayed: 123.84 -1.32 (1.05%)
Previous Close $125.16    52 Week High $108.63 
Open $125.27    52 Week Low $71.39 
Day High $126.95    P/E 68.42 
Day Low $123.67    EPS $1.81 
Volume 7,250,724